Downregulation of miR-16 expression was observed in OSCC patients and cancer cell lines, and this was negatively correlated with enhanced expression of its target gene, Tousled-like kinase 1 (TLK1) (Hu et al., 2018). The gene discussed is TLK1; the disease is cancer.